Literature DB >> 29945120

Inter-laboratory validation study of the ForenSeq™ DNA Signature Prep Kit.

Steffi Köcher1, Petra Müller2, Burkhard Berger2, Martin Bodner2, Walther Parson3, Lutz Roewer4, Sascha Willuweit4.   

Abstract

The implementation of massively parallel sequencing (MPS) in forensic science revealed the advantages of the new method compared to the forensic benchmark in DNA-STR analysis, the capillary-electrophoresis (CE): Sequence information and the possibility to multiplex hundreds of markers in one multiplex PCR increase the discrimination power of a forensic (STR-) profile. The EU funded project DNASeqEx (DNA-STR Massive Sequencing & International Information Exchange) aims to evaluate MPS-based materials in their respective developmental stages using the two established platforms MiSeq FGx (Illumina) and Ion S5™ (Thermo Fisher Scientific). As part of this project, we present here an inter-laboratory validation of the Forenseq™ DNA Signature Prep Kit, focussing on STRs included in primer mix A. Our study comprises tests of concordance, reproducibility, sensitivity (1 ng, 500 pg, 250 pg, 125 pg, 63 pg, 31 pg) and mixtures (male-male and male-female at ratios of 1:1, 1:5, 1:10, 1:15, 1:20, 1:100, 1:500, 1:1000). Sequencing results found to be virtually concordant to CE results, to reference profiles and reproducible between duplicates and between both laboratories. We observed first locus drop-outs (LDO) at a DNA input of 63 pg (20 sample pool) and 125 pg (38 sample pool). Alleles were found to be well balanced at a DNA input of 250 pg or more. We found the kit to perform well on moderate mixtures (1:1-1:20).
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Forensic genetics; Massively Parallel Sequencing; MiSeq FGx System; Next generation sequencing; Validation

Mesh:

Year:  2018        PMID: 29945120     DOI: 10.1016/j.fsigen.2018.05.007

Source DB:  PubMed          Journal:  Forensic Sci Int Genet        ISSN: 1872-4973            Impact factor:   4.882


  6 in total

1.  Utility of ForenSeq™ DNA Signature Prep Kit in the research of pairwise 2nd-degree kinship identification.

Authors:  Miao Xu; Qingqing Du; Guanju Ma; Zifan Chen; Qingxia Liu; Lihong Fu; Bin Cong; Shujin Li
Journal:  Int J Legal Med       Date:  2019-01-28       Impact factor: 2.686

2.  Development and validation of a novel 133-plex forensic STR panel (52 STRs and 81 Y-STRs) using single-end 400 bp massive parallel sequencing.

Authors:  Haoliang Fan; Lingxiang Wang; Changhui Liu; Xiaoyu Lu; Xuding Xu; Kai Ru; Pingming Qiu; Chao Liu; Shao-Qing Wen
Journal:  Int J Legal Med       Date:  2021-11-06       Impact factor: 2.791

3.  Concordance and characterization of massively parallel sequencing at 58 STRs in a Tibetan population.

Authors:  Hui Li; Cheng Zhang; Guoqing Song; Ke Ma; Yu Cao; Xueying Zhao; Qinrui Yang; Jianhui Xie
Journal:  Mol Genet Genomic Med       Date:  2021-02-25       Impact factor: 2.183

4.  Validation and beyond: Next generation sequencing of forensic casework samples including challenging tissue samples from altered human corpses using the MiSeq FGx system.

Authors:  Alina Senst; Amke Caliebe; Eva Scheurer; Iris Schulz
Journal:  J Forensic Sci       Date:  2022-03-22       Impact factor: 1.717

5.  Identification of sequence polymorphisms at 58 STRs and 94 iiSNPs in a Tibetan population using massively parallel sequencing.

Authors:  Dan Peng; Yinming Zhang; Han Ren; Haixia Li; Ran Li; Xuefeng Shen; Nana Wang; Erwen Huang; Riga Wu; Hongyu Sun
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

6.  Inter-laboratory study on standardized MPS libraries: evaluation of performance, concordance, and sensitivity using mixtures and degraded DNA.

Authors:  Petra Müller; Christian Sell; Thorsten Hadrys; Johannes Hedman; Steffi Bredemeyer; Francois-Xavier Laurent; Lutz Roewer; Sabrina Achtruth; Maja Sidstedt; Titia Sijen; Marc Trimborn; Natalie Weiler; Sascha Willuweit; Ingo Bastisch; Walther Parson
Journal:  Int J Legal Med       Date:  2019-11-19       Impact factor: 2.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.